CALR and cancer: Our research group has designed several DNA vaccines with enhanced antitumor effects by using E6 and/or E7 antigens from HPV-16 fused to a signal peptide from calreticulin to direct the antigen expression to the ER using the biolistic delivery method in a murine cancer model [107].